- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- March 2024
- 132 Pages
Global
From €846EUR$950USD£731GBP
- Report
- September 2024
Global
From €3427EUR$3,850USD£2,961GBP
- Book
- July 2023
- 304 Pages
- Book
- November 2011
- 864 Pages
€2597EUR$3,125USD£2,322GBP

The Immunoassay market is a segment of the In Vitro Diagnostics (IVD) industry. Immunoassays are laboratory tests used to detect and measure the presence of antigens or antibodies in a sample. These tests are used to diagnose and monitor a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Immunoassays are also used to detect and measure hormones, drugs, and other substances in the body.
Immunoassays are typically performed in a laboratory setting, but some tests are now available for use in point-of-care settings. Immunoassays are often used in combination with other tests to provide a more comprehensive diagnosis.
The Immunoassay market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Ortho Clinical Diagnostics, and bioMérieux. Show Less Read more